SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001512563-13-000001
Filing Date
2013-05-01
Accepted
2013-05-01 19:08:49
Documents
1
Period of Report
2012-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 1633
  Complete submission text file 0001512563-13-000001.txt   3362
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Issuer) CIK: 0001060426 (see all company filings)

IRS No.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address
Ai Bob Yunjun (Reporting) CIK: 0001512563 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32674 | Film No.: 13804939